Haofei Tiffany Wang

Haofei Tiffany Wang, MD, MBA, MS has a diverse work experience spanning over two decades. Currently, they hold the position of Vice President, Clinical Development at Tango Therapeutics since 2023. Before that, they served as the Senior Medical Director, Clinical Development at Omega Therapeutics from May 2022 to December 2023.

Prior to these roles, they worked at Ipsen for a significant period starting in 2016. There, they held multiple positions, including Medical Development Director from October 2020 to May 2022, Core Member of Cross-functional Asset Development Team from October 2016 to May 2022, Director of Biometrics and Head of Oncology Biostatistics from October 2018 to September 2021, and Principal Statistician and Associate Director, Biometrics from October 2016 to October 2018.

Before joining Ipsen, Haofei worked at Eli Lilly and Company. Their roles there included Associate Consultant Statistician from February 2014 to October 2016, Senior Statistician from October 2010 to February 2014, and Project Statistician from August 2006 to October 2010.

Their career in the biopharmaceutical industry started in 2004 at ImClone Systems Incorporated, which is now a part of Eli Lilly and Company. Haofei Tiffany worked there as a Research Associate from May 2004 to August 2005.

With their extensive experience in clinical development, biometrics, and statistics across various companies, Haofei brings a wealth of knowledge and expertise to their current role at Tango Therapeutics.

Haofei Tiffany Wang, MD, MBA, MS, completed their education at various institutions. Haofei Tiffany obtained an MBA degree from Indiana University - Kelley School of Business in 2011. Prior to that, they received a Master's degree in Statistics from The University of Georgia in 2004. In 2003, they completed a Master of Science (MS) in Biochemistry and Molecular Biology, also from The University of Georgia. Earlier in their educational journey, Haofei Tiffany Wang attended Capital University of Medical Sciences, where they pursued a degree in Medicine (MD) with a focus on Clinical Medicine.